Patient HLA-DRB1* and -DQB1* allele and haplotype association with hepatitis C virus persistence and clearance

Journal of General Virology

Volumn 91, Issue 8, 2010, Pages 1931-1938

  Ali, Lubna ^a   Mansoor, Atika ^a   Ahmad, Nafees ^a,b   Siddiqi, Saima ^a   Mazhar, Kehkashan ^a   Muazzam, Ambreen G ^a   Qamar, Raheel ^c,d   Khan, Khalid M ^e  

^a INSTITUTE OF BIOMEDICAL AND GENETIC ENGINEERING IBGE   (Pakistan)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Department of Electrical Computer Engineering   (Pakistan)

^d SHIFA COLLEGE OF MEDICINE   (Pakistan)

^e PMAS ARID AGRICULTURE UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INTERFERON; ANTIVIRUS AGENT; HLA DQ ANTIGEN; HLA-DRB1 ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CLEARANCE; CONTROLLED STUDY; DNA FINGERPRINTING; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAKISTAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; TREATMENT RESPONSE; VIRUS DETECTION; GENETICS; IMMUNOLOGY; MIDDLE AGED;

HEPATITIS C VIRUS;

ADULT; AGED; ALLELES; ANTIVIRAL AGENTS; FEMALE; HAPLOTYPES; HEPACIVIRUS; HEPATITIS C; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INTERFERONS; MALE; MIDDLE AGED; PAKISTAN; YOUNG ADULT;

EID: 77955283850     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.018119-0     Document Type: Article

References (52)

1. Aikawa, T., Kojima, M., Onishi, H., Tamura, R., Fukuda, S., Suzuki, T., Tsuda, F., Okamoto, H., Miyakawa, Y. & other authors (1996). HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C. J Med Virol 49, 274-278.
2. Alric, L., Izopet, J., Fort, M., Vinel, J. P., Fontenelle, P., Orfila, C., Payen, J. L., Sandres, K., Desmorat, H. & other authors (1999). Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection. Hum Immunol 60, 516-523. (Pubitemid 29296308)
3. Asti, M., Martinetti, M., Zavaglia, C., Cuccia, M. C., Gusberti, L., Tinelli, C., Cividini, A., Bruno, S., Salvaneschi, L. & other authors (1999). Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease. Hepatology 29, 1272-1279. (Pubitemid 29168765)
4. Bunce, M., O'Neill, C. M., Barnardo, M. C., Krausa, P., Browning, M. J., Morris, P. J. & Welsh, K. I. (1995). Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46, 355-367. (Pubitemid 26001354)
5. Corghi, D. B., Gonçales, N. S., Marques, S. B. & Gonçales, F. L., Jr (2008). Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection. Braz J Med Biol Res 41, 884-889.
6. Correa, P. A., Whitworth, W. C., Kuffner, T., McNicholl, J. & Anaya, J. M. (2002). HLA-DR and DQB1 gene polymorphism in the north-western Colombian population. Tissue Antigens 59, 436-439.
7. Cramp, M. E., Carucci, P., Underhill, J., Naoumov, N. V., Williams, R. & Donaldson, P. T. (1998). Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J Hepatol 29, 207-213. (Pubitemid 28352805)
8. Cursino-Santos, J. R., Donadi, E. A., Martinelli, A. L., Louzada-Junior, P. & Martinez-Rossi, N. M. (2007). Evolution of hepatitis C virus infection under host factor influence in an ethically complex population. Liver Int 27, 1371-1378.
9. El-Chennawi, F. A., Auf, F. A., Metwally, S. S., Mosaad, Y. M., El-Wahab, M. A. & Tawhid, Z. E. (2008). HLA-class II alleles in Egyptian patients with hepatocellular carcinoma. Immunol Invest 37, 661-674.
10. Fanning, L. J., Levis, J., Kenny-Walsh, E., Wynne, F., Whelton, M. & Shanahan, F. (2000). Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population. Hepatology 31, 1334-1337. (Pubitemid 30351296)
11. Fanning, L. J., Levis, J., Kenny-Walsh, E., Whelton, M., O'Sullivan, K. & Shanahan, F. (2001). HLA class II genes determine the natural variance of hepatitis C viral load. Hepatology 33, 224-230. (Pubitemid 32016906)
12. Fanning, L. J., Kenny-Walsh, E. & Shanahan, F. (2004). Persistence of hepatitis C virus in a white population: associations with human leukocyte antigens class I. Hum Immunol 65, 745-751. (Pubitemid 39061173)
13. García-Sastre, A. & Biron, C. A. (2006). Type 1 interferons and the virus-host relationship: a lesson in détente. Science 312, 879-882. (Pubitemid 43727313)
14. Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H. & other authors (2009). Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399-401.
15. Harcourt, G., Hellier, S., Bunce, M., Satsangi, J., Collier, J., Chapman, R., Phillips, R. & Klenerman, P. (2001). Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection. J Viral Hepat 8, 174-179. (Pubitemid 32506629)
16. Hnatyszyn, H. J. (2005). Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther 10, 1-11. (Pubitemid 40767627)
17. Hohler, T., Gerken, G., Notghi, A., Knolle, P., Lubjuhn, R., Taheri, H., Schneider, P. M., Meyer zum Buschenfelde, K. H. & Rittner, C. (1997). MHC class II genes influence the susceptibility to chronic active hepatitis C. J Hepatol 27, 259-264.
18. Hong, X., Yu, R. B., Sun, N. X., Wang, B., Xu, Y. C. & Wu, G. L. (2005). Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis. World J Gastroenterol 11, 7302-7307. (Pubitemid 43137680)
19. Hue, S., Cacoub, P., Renou, C., Halfon, P., Thibault, V., Charlotte, F., Picon, M., Rifflet, H., Piette, J. & other authors (2002). Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. J Infect Dis 186, 106-109.
20. Idrees, M. & Riazuddin, S. (2008). Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis 8, 69. (Pubitemid 351803135)
21. Iminishi, T., Akaza, T., Kimura, A., Tokunaga, K. & Gojobori, T. (1992). Estimation of allele and haplotype frequencies for HLA and complement loci. In HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference, vol. I, pp. 76-79. Edited by K. Tsuji, M. Aizawa & T. Sasazuki. Oxford: Oxford University Press.
22. Jiao, J. & Wang, J. B. (2005). Hepatitis C virus genotypes, HLA-DRB alleles and their response to interferon-a and ribavirin in patients with chronic hepatitis C. Hepatobiliary Pancreat Dis Int 4, 80-83. (Pubitemid 40347520)
23. Kamal, S. M., Fehr, J., Roesler, B., Peters, T. & Rasenack, J. W. (2002). Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology 123, 1070-1083.
24. Kikuchi, I., Ueda, A., Mihara, K., Miyanaga, O., Machidori, H., Ishikawa, E. & Tamura, K. (1998). The effect of HLA alleles on response to interferon therapy in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol 10, 859-863. (Pubitemid 28493263)
25. Kryczka, W., Brojer, E., Kalinska, A., Urbaniak, A. & Zarebska- Michaluk, D. (2001). DRB1 alleles in relation to severity of liver disease in patients with chronic hepatitis C. Med Sci Monit 7 (Suppl. 1), 217-220.
26. Ksiaa, L., Ayed-Jendoubi, S., Sfar, I., Gorgi, Y., Najjar, H. A., Abdallah, T. B. & Ayed, K. (2007). Clearance and persistence of hepatitis C virus in a Tunisian population: association with HLA class I and class II. Viral Immunol 20, 312-319. (Pubitemid 47076212)
27. Kuzushita, N., Hayashi, N., Moribe, T., Katayama, K., Kanto, T., Nakatani, S., Kaneshige, T., Tatsumi, T., Ito, A. & other authors (1998). Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology 27, 240-244. (Pubitemid 28041560)
28. Lloyd, A. R., Jagger, E., Post, J. J., Crooks, L.-A., Rawlinson, W. D., Hahn, Y. S. & Ffrench, R. A. (2007). Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection. Immunol Cell Biol 85, 24-32. (Pubitemid 46067318)
29. López-Vázquez, A., Rodrigo, L., Miña-Blanco, A., Mart́nez-Borra, J., Fuentes, D., Rodríguez, M., Pérez, R., González, S. & López-Larrea, C. (2004). Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis 189, 957-963.
30. Mangia, A., Gentile, R., Cascavilla, I., Margaglione, M., Villani, M. R., Stella, F., Modola, G., Agostiano, V., Gaudiano, C. & Andriulli, A. (1999). HLA class II favors clearance of HCV infection and progression of the chronic liver damage. J Hepatol 30, 984-989. (Pubitemid 29278740)
31. McKiernan, S. M., Hagan, R., Curry, M., McDonald, G. S., Kelly, A., Nolan, N., Walsh, A., Hegarty, J., Lawlor, E. & Kelleher, D. (2004). Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 40, 108-114. (Pubitemid 38877575)
32. Minton, E. J., Smillie, D., Neal, K. R., Irving, W. L., Underwood, J. C. & James, V. (1998). Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group. J Infect Dis 178, 39-44.
33. + memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol 77, 4781-4793.
34. Ohno, O., Mizokami, M., Wu, R. R., Saleh, M. G., Ohba, K., Orito, E., Mukaide, M., Williams, R. & Lau, J. Y. (1997). New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 35, 201-207. (Pubitemid 26422655)
35. Qamar, R., Ayub, Q., Mohyuddin, A., Helgason, A., Mazhar, K., Mansoor, A., Zerjal, T., Tyler-Smith, C. & Mehdi, S. Q. (2002). Y chromosomal DNA variation in Pakistan. Am J Hum Genet 70, 1107-1124.
36. Raja, N. S. & Janjua, K. A. (2008). Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect 41, 4-8. (Pubitemid 351792115)
37. Reich, D., Thangaraj, K., Patterson, N., Price, A. L. & Singh, L. (2009). Reconstructing Indian population history. Nature 461, 489-494.
38. Roe, D. L., Lewis, R. E. & Cruse, J. M. (2000). Association of HLA-DQ and -DR alleles with protection from or infection with HIV-1. Exp Mol Pathol 68, 21-28.
39. Sadler, A. J. & Williams, B. R. (2008). Interferon-inducible antiviral effectors. Nat Rev Immunol 8, 559-568.
40. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
41. Scotto, G., Fazio, V., D'Alessandro, G., Monno, L., Saracino, A., Palumbo, E. & Angarano, G. (2003). Association between HLA class II antigens and hepatitis C virus infection. J Biol Regul Homeost Agents 17, 316-321. (Pubitemid 38443661)
42. Singh, R., Kaul, R., Kaul, A. & Khan, K. (2007). A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 13, 1770-1787. (Pubitemid 46706009)
43. Sinn, D. H., Paik, S. W., Kang, P., Kil, J. S., Park, S. U., Lee, S. Y., Song, S. M., Gwak, G. Y., Choi, M. S. & other authors (2008). Disease progression and the risk factor analysis for chronic hepatitis C. Liver Int 28, 1363-1369.
44. Thio, C. L., Thomas, D. L., Goedert, J. J., Vlahov, D., Nelson, K. E., Hilgartner, M. W., O'Brien, S. J., Karacki, P., Marti, D. & other authors (2001). Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis 184, 16-21.
45. Thursz, M., Yallop, R., Goldin, R., Trepo, C. & Thomas, H. C. (1999). Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet 354, 2119-2124.
46. Tillmann, H. L., Chen, D. F., Trautwein, C., Kliem, V., Grundey, A., Berning-Haag, A., Boker, K., Kubicka, S., Pastucha, L. & other authors (2001). Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease. Gut 48, 714-718. (Pubitemid 32378596)
47. Vejbaesya, S., Songsivilai, S., Tanwandee, T., Rachaibun, S., Chantangpol, R. & Dharakul, T. (2000). HLA association with hepatitis C virus infection. Hum Immunol 61, 348-353. (Pubitemid 30117805)
48. Wang, L. Y., Lin, H. H., Lee, T. D., Wu, Y. F., Hu, C. T., Cheng, M. L. & Lo, S. Y. (2005). Human leukocyte antigen phenotypes and hepatitis C viral load. J Clin Virol 32, 144-150.
49. Yee, L. J. (2004). Host genetic determinants in hepatitis C virus infection. Genes Immun 5, 237-245. (Pubitemid 38967177)
50. Yenigün, A. & Durupinar, B. (2002). Decreased frequency of the HLA-DRB1* 11 allele in patients with chronic hepatitis C virus infection. J Virol 76, 1787-1789. (Pubitemid 34094626)
51. Yoon, S. K., Han, J. Y., Pyo, C. W., Yang, J. M., Jang, J. W., Kim, C. W., Chang, U. I., Bae, S. H., Choi, J. Y. & other authors (2005). Association between human leukocytes antigen alleles and chronic hepatitis C virus infection in the Korean population. Liver Int 25, 1122-1127. (Pubitemid 41782554)
52. Yoshizawa, K., Ota, M., Saito, S., Maruyama, A., Yamaura, T., Rokuhara, A., Orii, K., Ichijo, T., Matsumoto, A. & other authors (2003). Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease. Tissue Antigens 61, 159-165. (Pubitemid 36549602)